Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Prices via Intrinio. Supplier and customer ties are extracted from SEC filings and carry the sentence they came from. Not investment advice.
Kymera Therapeutics, Inc.
Price, suppliers and customers from SEC filings, institutional ownership and the next report.
Biological Products, (No Diagnostic Substances)
No intraday reading yet this session.
282 institutional managers report a position in Kymera Therapeutics, Inc. worth $11.2B between them, filed on form 13F for the quarter ending 2026-06-30. 21 of them hold 80% of it, the largest being FMR LLC at 12.63%.
257 more managers in the register
21 managers hold 80% of the $11.2B institutional base. The other 261 hold the rest.
Positions as filed with the SEC for the quarter ended Jun 30. A 13F is due 45 days after the quarter closes, so this register is 78 days old and does not move with the price above it.
KYMR (Kymera Therapeutics, Inc.) has 2 disclosed suppliers and 4 disclosed customers, strongest disclosure first.
Suppliers:
Customers:
Select a tie for the filing sentence that discloses it; select again to open the company. Lines are disclosed suppliers and customers, coloured by industry; the closer to the centre, the more the filings disclose. A dot is green or red by today’s move. Extended: satellites hang off single companies, not bundled sectors.
Largest move on the map today: SNY +0.12%, in industrials & materials.
via Baker Bros. Advisors LP, venBio Select Advisor LLC, Wellington Management Group LLP +8 more · 8.86% of KYMR, 8.92% of MDGL
via venBio Select Advisor LLC, BVF Inc, Wellington Management Group LLP +5 more · 7.65% of KYMR, 9.62% of GPCR
via Baker Bros. Advisors LP, venBio Select Advisor LLC, Wellington Management Group LLP +9 more · 8.86% of KYMR, 13.53% of CELC
via Baker Bros. Advisors LP, T. Rowe Price Investment Management, Inc., Wellington Management Group LLP +3 more · 8.86% of KYMR, 9.52% of IMTX
via Baker Bros. Advisors LP, venBio Select Advisor LLC, Franklin Resources Inc +3 more · 8.86% of KYMR, 9.14% of FTH
via T. Rowe Price Investment Management, Inc., Wellington Management Group LLP, venBio Select Advisor LLC +9 more · 6.40% of KYMR, 11.16% of CYTK
Managers holding a meaningful stake in KYMR also hold this much of the other company’s institutional base. Managers who hold most of the companies we cover are excluded, because their overlap says nothing about this one in particular. This is how the two are held, not evidence that one moves the other.